Literature DB >> 18166559

Outcomes of extremely low birth weight (<1 kg) and extremely low gestational age (<28 weeks) infants with bronchopulmonary dysplasia: effects of practice changes in 2000 to 2003.

Kristen Kobaly1, Mark Schluchter, Nori Minich, Harriet Friedman, Hudson Gerry Taylor, Deanne Wilson-Costello, Maureen Hack.   

Abstract

OBJECTIVE: The goal was to evaluate whether changes in neonatal intensive care have improved outcomes for children with bronchopulmonary dysplasia (oxygen dependence at corrected age of 36 weeks).
METHODS: We compared outcomes of extremely low birth weight (<1 kg) and extremely low gestational age (<28 weeks) infants with bronchopulmonary dysplasia between 2 periods (period I, 1996-1999: extremely low birth weight, n = 122; extremely low gestational age, n = 118; period II, 2000-2003: extremely low birth weight, n = 109; extremely low gestational age, n = 107).
RESULTS: For both groups, significant practice changes between period I and period II included increased prenatal and decreased postnatal steroid therapy and increased surfactant therapy, indomethacin therapy, and patent ductus arteriosus ligation. Significant morbidity changes included decreased rates of severe cranial ultrasound abnormalities and increased rates of ventilator dependence. Rates of bronchopulmonary dysplasia did not change (52% vs 53%). Follow-up evaluation revealed significantly lower rates of neurosensory abnormalities during period II (extremely low birth weight: 29% vs 16%; extremely low gestational age: 31% vs 16%). There were no changes in rates of Mental Developmental Index scores of <70 (extremely low birth weight: 42% vs 42%; extremely low gestational age: 37% vs 45%) or overall developmental impairment (extremely low birth weight: 51% vs 49%; extremely low gestational age: 50% vs 51%). For the extremely low gestational age group, predictors of neurosensory abnormalities were severe cranial ultrasound abnormality and postnatal steroid therapy. Predictors of overall impairment included severe cranial ultrasound abnormalities, ventilator dependence, postnatal steroid therapy, and patent ductus arteriosus ligation. For the extremely low birth weight group, the only predictor of neurosensory abnormalities was severe cranial ultrasound abnormality. Predictors of overall impairment included multiple birth, ventilator dependence, and severe cranial ultrasound abnormalities.
CONCLUSIONS: Neurosensory outcomes of infants with bronchopulmonary dysplasia improved during 2000 to 2003 but overall neurodevelopmental outcomes did not change.

Entities:  

Mesh:

Year:  2008        PMID: 18166559     DOI: 10.1542/peds.2007-1444

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  27 in total

1.  The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.

Authors:  Jeff Reese; Matthew M Laughon
Journal:  J Pediatr       Date:  2015-08-24       Impact factor: 4.406

2.  Deep Illumina sequencing reveals differential expression of long non-coding RNAs in hyperoxia induced bronchopulmonary dysplasia in a rat model.

Authors:  Han-Rong Cheng; Shao-Ru He; Ben-Qing Wu; Dong-Cai Li; Tian-Yong Hu; Li Chen; Zhu-Hui Deng
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 3.  Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances.

Authors:  Joseph J Volpe
Journal:  Lancet Neurol       Date:  2009-01       Impact factor: 44.182

4.  Thy-1 signals through PPARγ to promote lipofibroblast differentiation in the developing lung.

Authors:  Brian M Varisco; Namasivayam Ambalavanan; Jeffrey A Whitsett; James S Hagood
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-20       Impact factor: 6.914

5.  Glutamate receptors: the cause or cure in perinatal white matter injury?

Authors:  R Douglas Fields
Journal:  Neuron Glia Biol       Date:  2012-01-05

Review 6.  Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?

Authors:  Clyde J Wright; Haresh Kirpalani
Journal:  Pediatrics       Date:  2011-06-06       Impact factor: 7.124

7.  Response to bronchodilators in very preterm infants with evolving bronchopulmonary dysplasia.

Authors:  Daniel K Morrow; Diane Schilling; Cindy T McEvoy
Journal:  Res Rep Neonatol       Date:  2015-12-02

Review 8.  Developmental regulation of antioxidant enzymes and their impact on neonatal lung disease.

Authors:  Sara K Berkelhamer; Kathryn N Farrow
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

Review 9.  The encephalopathy of prematurity--brain injury and impaired brain development inextricably intertwined.

Authors:  Joseph J Volpe
Journal:  Semin Pediatr Neurol       Date:  2009-12       Impact factor: 1.636

10.  Improved weight attainment of extremely low-gestational-age infants with bronchopulmonary dysplasia.

Authors:  J Madden; K Kobaly; N M Minich; M Schluchter; D Wilson-Costello; M Hack
Journal:  J Perinatol       Date:  2009-10-01       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.